
GMAB vs GSK
$GMAB vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GMAB vs GSK: trend, levels and the market
One year to 2026-11-16, against the S&P 500 (+11.2%). Split-adjusted daily closes.
- ·GMAB has the cleaner trend, above both its 50- and 200-day averages, where GSK is above one and below the other.
- ·Only GMAB beat the market over the past year, by 58.4%, while GSK trailed the S&P 500 at +11.2% by 5.1%.
- ·GSK has support 0.6% below at $49.63; GMAB has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
GMAB vs GSK: the quick read
- ·GSK is the larger company by market cap ($101.97B vs $32.18B).
- ·GMAB has been more active on our scanner (185 vs 69 alerts in 30 days).
- ·GMAB has the smaller float (615.9M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 185 and 69 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·GSK pays a dividend and GMAB does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching GMAB or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GMAB and GSK on TheDesperateTrader.
- Is GMAB or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($101.97B vs $32.18B). GMAB has been more active on our scanner (185 vs 69 alerts in 30 days). GMAB has the smaller float (615.9M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GMAB and GSK?
- The differences that matter: GSK is roughly 3x the size of the other by market cap ($32.18B vs $101.97B); they trade at very different share prices ($51.39 vs $49.95); GMAB sits at 76% of its 52-week range against 26% for GSK; only GSK pays a dividend; our scanner flagged GMAB 185 times in the last 30 days against 69 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of GMAB and GSK is more active right now?
- Right now GMAB is at about 0.4x its normal volume and GSK is at about 0.6x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is GMAB or GSK in the stronger trend?
- GMAB is above its 50-day average of $41.51 and above its 200-day average of $31.63; GSK is above its 50-day average of $49.31 and below its 200-day average of $52.40. GMAB leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GMAB or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GMAB and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.